Egyptian group developing Ebola vaccine

An Egyptian pharmaceutical firm is developing a potential vaccine against the deadly Ebola strain raging in the Democratic Republic of Congo (DRC), it announced Thursday.

Early trials for 'common cold' vaccine offer encouraging signs

A vaccine designed to protect against rhinoviruses, which cause the great majority of common colds and exacerbate chronic respiratory illnesses, has shown encouraging early results in a phase 1 clinical trial. Initial findings ...

page 26 from 40